Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Income from Continuing Operations (2016 - 2025)

Angiodynamics (ANGO) has disclosed Income from Continuing Operations for 16 consecutive years, with 6350000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 40.86% year-over-year to 6350000.0, compared with a TTM value of 27710000.0 through Nov 2025, up 87.67%, and an annual FY2025 reading of 33993000.0, up 81.56% over the prior year.
  • Income from Continuing Operations was 6350000.0 for Q4 2025 at Angiodynamics, up from 10903000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 45884000.0 in Q3 2023 and bottomed at 187736000.0 in Q1 2024.
  • Average Income from Continuing Operations over 5 years is 16879800.0, with a median of 8985500.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations surged 452.85% in 2023, then crashed 1879.29% in 2024.
  • Year by year, Income from Continuing Operations stood at 8351000.0 in 2021, then fell by 1.62% to 8486000.0 in 2022, then tumbled by 242.3% to 29048000.0 in 2023, then soared by 63.03% to 10738000.0 in 2024, then surged by 40.86% to 6350000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for ANGO at 6350000.0 in Q4 2025, 10903000.0 in Q3 2025, and 6050000.0 in Q2 2025.